Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima

Updated on: March 30,2024

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima

Updated on:March 30,2024

Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva

Updated on: January 16,2024

Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva

Updated on:January 16,2024

Research finds cancer immunotherapy does not interfere with COVID-19 immunity

bySaint Louis UniversityCredit: Unsplash/CC0 Public DomainResearch findings published inFrontiers in Immunologyshow that cancer immunotherapy does not interfere with COVID-19 immunit

Updated on: January 23,2024

Research finds cancer immunotherapy does not interfere with COVID-19 immunity

bySaint Louis UniversityCredit: Unsplash/CC0 Public DomainResearch findings published inFrontiers in Immunologyshow that cancer immunotherapy does not interfere with COVID-19 immunit

Updated on:January 23,2024

Putting the brakes on tumor stealth

by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how

Updated on: April 01,2024

Putting the brakes on tumor stealth

by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how

Updated on:April 01,2024

Researchers identify protein that contributes to racial disparities in prostate cancer

by Roswell Park Cancer InstituteDrs. Dhyan Chandra, left, and Rahul Kumar led the Roswell Park research team that has proposed a new strategy for treating prostate cancer in some men. Credit: Ros

Updated on: June 22,2024

Researchers identify protein that contributes to racial disparities in prostate cancer

by Roswell Park Cancer InstituteDrs. Dhyan Chandra, left, and Rahul Kumar led the Roswell Park research team that has proposed a new strategy for treating prostate cancer in some men. Credit: Ros

Updated on:June 22,2024

AI tool developed to help grade cancer based on cell divisions

by University of WarwickCells dividing under the microscope. Credit: University of WarwickAhead of World Cancer Day on 4 February, scientists are revealing a cutting-edge artificial intelligence

Updated on: March 05,2024

AI tool developed to help grade cancer based on cell divisions

by University of WarwickCells dividing under the microscope. Credit: University of WarwickAhead of World Cancer Day on 4 February, scientists are revealing a cutting-edge artificial intelligence

Updated on:March 05,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on: March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on:March 30,2024

New preclinical model could accelerate research on thymic cancer

byWeill Cornell Medical CollegeCredit: AI-generated imageA new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutat

Updated on: January 12,2024

New preclinical model could accelerate research on thymic cancer

byWeill Cornell Medical CollegeCredit: AI-generated imageA new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutat

Updated on:January 12,2024

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on: March 01,2024

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on:March 01,2024

Study supports PSA screening for male BRCA2 carrier

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of theBRCA2mutation, which is associated with a higher incidence of prostate cancer, yo

Updated on: May 25,2024

Study supports PSA screening for male BRCA2 carrier

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of theBRCA2mutation, which is associated with a higher incidence of prostate cancer, yo

Updated on:May 25,2024

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on: November 30,2024

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on:November 30,2024